Showing results (671-680 of 7,007) with videos related to

Sort By:
Pageof 701
Lung Cancer (Amsterdam, Netherlands)|February 13, 2001
Alteration of cell growth and morphology by overexpression of transforming growth factor beta type II receptor in human lung adenocarcinoma cellsT K Kim, E K Mo, C G Yoo, et al.
Lung Cancer (Amsterdam, Netherlands)|February 13, 2001
Prostaglandin E2 and vasoactive intestinal peptide increase vascular endothelial cell growth factor mRNAs in lung cancer cellsM Casibang, S Purdom, S Jakowlew, et al.
Lung Cancer (Amsterdam, Netherlands)|February 13, 2001
Phase I study of paclitaxel (Taxol) plus vinorelbine (Navelbine) in patients with untreated stage IIIb and IV non-small cell lung cancerJ L Breton, V Westeel, P Jacoulet, et al.
Lung Cancer (Amsterdam, Netherlands)|February 13, 2001
Intramedullary spinal cord metastases (ISCM) and non-small cell lung carcinoma (NSCLC): clinical patterns, diagnosis and therapeutic considerationsA Potti, M Abdel-Raheem, R Levitt, et al.
Lung Cancer (Amsterdam, Netherlands)|April 28, 2001
Topoisomerase IIalpha and other drug resistance markers in advanced non-small cell lung cancerA C Dingemans, J van Ark-Otte, S Span, et al.
Lung Cancer (Amsterdam, Netherlands)|April 28, 2001
Paclitaxel added to the cisplatin/etoposide regimen in extensive-stage small cell lung cancer -- the use of complete response rate as the primary endpoint in phase II trialsA Dowlati, L Crosby, S C Remick, et al.
Lung Cancer (Amsterdam, Netherlands)|September 15, 2001
Treatment and survival of patients with non-small cell lung cancer Stage IIIA diagnosed in 1989-1994: a study in the region of the Comprehensive Cancer Centre East, The NetherlandsJ A van Dijck, J Festen, E M de Kleijn, et al.
Lung Cancer (Amsterdam, Netherlands)|January 22, 2021
Salvage surgery for non-small cell lung cancer after tyrosine kinase inhibitor treatmentYoichi Ohtaki, Kimihiro Shimizu, Hiroyuki Suzuki, et al.
Lung Cancer (Amsterdam, Netherlands)|January 23, 2021
Caspr2 autoantibody-associated Morvan syndrome predating thymoma relapse by 30 monthsPegah Masrori, Hannah Vaesen Bentein, Jo Raskin, et al.
Lung Cancer (Amsterdam, Netherlands)|September 15, 2019
A meta-analysis of adjuvant EGFR-TKIs for patients with resected non-small cell lung cancerHua Cheng, Xiao-Jian Li, Xiao-Jin Wang, et al.
Pageof 701